En route to early diagnosis of Alzheimer's disease--are we there yet?

@article{Fradinger2005EnRT,
  title={En route to early diagnosis of Alzheimer's disease--are we there yet?},
  author={Erica A. Fradinger and Gal Bitan},
  journal={Trends in biotechnology},
  year={2005},
  volume={23 11},
  pages={531-3}
}
As therapeutics for Alzheimer's disease (AD) become available, it will become increasingly important to develop accurate and reliable tools for its early diagnosis. A recent paper by Georganopoulou et al. suggests that nanobiotechnology could help to overcome the limitations with the current diagnostic methods. The paper introduces a nanoparticle-based assay using antibodies that are specific for amyloid beta-protein (Abeta) oligomers with sub-femtomolar sensitivity. This assay appears to be… CONTINUE READING

From This Paper

Topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 24 references

Alzheimer’s disease-affected brain: presence of oligomeric Ab ligands (ADDLs) suggests a molecular basis for reversible memory loss

  • Y Gong
  • Proc. Natl. Acad. Sci. U. S. A
  • 2003

Similar Papers

Loading similar papers…